Michael Lauseker, Markus Pfirrmann, Verena S. Hoffmann, and Joerg Hasford. 2012. “Comment on ‘Second-Generation Tyrosine Kinase Inhibitors Improve the Survival of Patients With Chronic Myeloid Leukemia in Whom Imatinib Therapy Has failed’ Haematologica 2011;96(12):1779–82”. Haematologica 97 (5). Pavia, Italy, e14-e15. https://doi.org/10.3324/haematol.2011.061630.